TherapeuticsMD (TXMD) FCF Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
TherapeuticsMD (TXMD) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 1,688.00 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -1,334.00 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1,096.00 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -672.00 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 1,020.00 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -518.00 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 1,090.00 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 869.00 |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | 4,962.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,962.00 |
| Mar 31, 2026 | -4,748.00 |
| Dec 31, 2025 | 3,944.00 |
| Sep 30, 2025 | 14,040.00 |
| Jun 30, 2025 | -58,092.00 |
| Mar 31, 2025 | 25,103.00 |
| Dec 31, 2024 | 145,096.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 128,662.00 |
| Mar 31, 2024 | 202,299.00 |
| Dec 31, 2023 | -148,140.00 |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | 528,260.00 |
| Mar 31, 2023 | 48,140.00 |
| Dec 31, 2022 | -22,401.00 |
| Sep 30, 2022 | 515,469.00 |
| Jun 30, 2022 | -583,275.00 |
| Mar 31, 2022 | -238,404.00 |
| Dec 31, 2021 | 39,220.00 |
| Sep 30, 2021 | 2,593.00 |